Chromogenic
Products (3)
CHROMagar Candida Plus
Candida auris is an emerging fungal pathogen first identified in Japan in 2005. This yeast can cause severe, potentially life-threatening infections, often resistant to multiple antifungal drugs. C. auris exists in at least four distinct genetic groups (clades). Strains from some clades are more likely to cause severe infections. Skin colonization is a significant concern in C. auris outbreaks, highlighting the importance of thorough patient screening to prevent further spread. Until CHROMagar™ Candida was the primary rapid culture-based method for screening for Candida species.
CHROMagar CCA
Water contaminated with microorganisms, particularly bacteria, poses significant health risks. Fecal contamination from human and animal waste can contaminate water sources, leading to serious health issues. While directly testing for all pathogens is challenging, monitoring E. coli levels is crucial. E. coli, a bacterium found exclusively in the intestines of humans and animals, serves as a reliable indicator of fecal contamination. Therefore, accurate and efficient monitoring of E. coli levels in water resources is essential for safeguarding public health.
CHROMagar MRSA
Staphylococcus aureus is a significant human pathogen, frequently encountered in various clinical settings. The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has significantly complicated treatment due to its resistance to beta-lactam antibiotics. This has led to an increase in healthcare-associated infections. Accurate and rapid screening for MRSA is crucial for effective treatment and infection control. Selective media play a vital role by facilitating the isolation of S. aureus and the simultaneous detection of methicillin resistance.